Allele‐specific silencing of the dominant disease allele in sialuria by RNA interference
Open Access
- 24 July 2008
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 22 (11) , 3846-3852
Abstract
Dominant disease alleles are attractive therapeutic targets for allele‐specific gene silencing by small interfering RNA (siRNA). Sialuria is a dominant disorder caused by missense mutations in the allosteric site of GNE , coding for the rate‐limiting enzyme of sialic acid biosynthesis, UDP‐GlcNAc 2‐epimerase/ManNAc kinase. The resultant loss of feedback inhibition of GNE epimerase activity by CMP‐sialic acid causes excessive production of free sialic acid. For this study we employed synthetic siRNAs specifically targeting the dominant GNE mutation c.797G>A (p.R266Q) in sialuria fibroblasts. We demonstrated successful siRNA‐mediated down‐regulation of the mutant allele by allele‐specific real‐time PCR. Importantly, mutant allele‐specific silencing resulted in a significant decrease of free sialic acid, to within the normal range. Feedback inhibition of GNE‐epimerase activity by CMP‐sialic acid recovered after silencing demonstrating specificity of this effect. These findings indicate that allele‐specific silencing of a mutated allele is a viable therapeutic strategy for autosomal dominant diseases, including sialuria.— Klootwijk, R. D., Savelkoul, P. J. M., Ciccone, C., Manoli, I., Caplen, N. J., Krasnewich, D. M., Gahl, W. A., Huizing, M. Allele‐specific silencing of the dominant disease allele in sialuria by RNA interference. FASEB J. 22, 3846–3852 (2008)Keywords
Funding Information
- National Cancer Institute
- National Institutes of Health
This publication has 44 references indexed in Scilit:
- Single-Nucleotide-Specific siRNA Targeting in a Dominant-Negative Skin ModelJournal of Investigative Dermatology, 2008
- Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Journal of Clinical Investigation, 2007
- Antisense-mediated exon skipping: A versatile tool with therapeutic and research applicationsRNA, 2007
- Chemical Genetics: Elucidating Biological Systems with Small-Molecule CompoundsJournal of Investigative Dermatology, 2007
- RNA Interference–Mediated Suppression and Replacement of Human Rhodopsin In VivoThe American Journal of Human Genetics, 2007
- Transgenic Small Interfering RNA Halts Amyotrophic Lateral Sclerosis in a Mouse ModelJournal of Biological Chemistry, 2005
- Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic miceMolecular Therapy, 2005
- Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity.Journal of Clinical Investigation, 1995
- Clinical and Biochemical Studies in an American Child with SialuriaBiochemical Medicine and Metabolic Biology, 1993